Ati-045
Atopic Dermatitis, Dermatitis, Eczema, Atopic, Ad
Phase II
Recruiting
ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
May 27, 2025
―
Ati-2138
Atopic Dermatitis
Phase II
Completed
Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis
Sep 03, 2024
―
Ati-450
Psoriatic Arthritis
Phase II
Terminated
Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
Jul 29, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Aclaris Therapeutics (8AT) have in its pipeline
8AT is currently developing the following drugs: Ati-045, Ati-2138, Ati-450. These drug candidates are in various stages of clinical development as the company works toward FDA approval.